Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-010672
Filing Date
2025-12-23
Accepted
2025-12-23 16:20:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3324
  Complete submission text file 0001950047-25-010672.txt   4872
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Subject) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42001 | Film No.: 251600851
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3565 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address
Lorrain Daniel S. (Reporting) CIK: 0001861550 (see all company filings)

Type: 144